Transcultural Validation of the Physical Activity Scale for Individuals With Physical Disabilities (PASIPD) in French: The PASIPD-Fr
NCT ID: NCT04061616
Last Updated: 2025-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2017-07-01
2019-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health-Enhancing Adapted Physical Activity Program at "Mon Stade"
NCT04716322
Leisure Physical Activity and Barriers to Physical Activity
NCT05816148
Follow-Up of Fitness in Overweight Patients Treated With Physical Activity
NCT03754478
Effect of a Physical-activity-promoting Environment on Motor Skills, Physical Activity and Quality of Life of Children in Childcare Settings
NCT00967460
Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD)
NCT04922190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the validation, the investigators used the international recommendations for cross-cultural translation and adaptation of questionnaires. Population was individuals with neurological disease (stroke, multiple sclerosis, Parkinson disease and neuromuscular disorders) with significant in physical disability. Patients were invited in an ambulatory setting. Data collected for every participant included demographic and general variables (age, sex, level, cause and time since neurological disease, walking capacities and aid), scores of a physical performance tests (10 Meter Walking Test, 10 MWT) and the 4 self-administered questionnaires: the Dijon Physical Activity Scale (PAS) the Activities-specific Balance Confidence (ABC) Scale, the Medical Outcome Study Short Form 12 " (MOS SF-12) and the Hospital Anxiety and Depression (HAD) scale.
Face validity was assessed using verbal feedbacks from physician and patients, and the mean time to fill-out the scale.
Criterion validity was assessed with correlation and discrimination analysis between the scores for the PASIPD-Fr and the Dijon PAS.
Construct validity was assessed using the correlation with scores of instruments that measure various aspects related to and physical activity (convergent validity) such as the self-reported questionaires ABC, SF-12 and HAD scales and also the 10 MWT.
For consistency and reliability, the investigators calculated the Cronbach α coefficient and calculated the ICC between 2 completions at a 2-week interval.
Sample calculation was based on an expected ICC \> 0.9, which required 50 participants to reject the hypothesis that the actual ICC is \< 0.6, which corresponds to the lower limit for a "good" reproducibility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
All the participants volunteer to participate to the study that were included.
PASIPD-Fr
Fill-out the PASIPD-Fr self questionaire twice (2 completions at a 2-week interval)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PASIPD-Fr
Fill-out the PASIPD-Fr self questionaire twice (2 completions at a 2-week interval)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient affiliated to a social security system
* Patient over 18 years of age
* Patients with physical disabilities (Act No. 2005-102 on equal rights and opportunities)
* Individuals with the following disease: stroke survivors, multiple sclerosis, neuromuscular disease and idiopathic Parkinson's disease
Exclusion Criteria
* Patients under guardianship or curators or protection of justice.
* Lack of informed information about the study
* Alteration of higher functions or sensory disturbance making it impossible to understand and adhere to the research protocol
* A severe medical condition that significantly alters functional abilities (severe heart failure, respiratory failure, unstable metabolic disorders such as active renal failure) and involves a life-threatening condition in the short to medium term (progressive neoplastic pathology, unstable systemic disease).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Caen Normandie
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PASIPD-Fr
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.